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Background
MRI is the current reference-standard for quantification of
systolic left and right ventricular (LV/RV-) function. How-
ever, the conventional three-dimensional quantitative
assessment of LV and RV-ejection fraction (EF), is time
consuming and operator-dependant. The mitral/tricuspid
annular plane systolic excursion (MAPSE/TAPSE) towards
the apex, on the other hand, can be easily and promptly
quantified on MR-images and has been previously shown
to, correlate with LV- and RVEF and with the prognosis of
patients with heart failure in echocardiographic studies.
The aim of this study was to compare the value of MAPSE
and TAPSE to the conventional LVEF and RVEF assess-
ment and to the well established biomarker NTproBNP in
heart failure.
Methods
Using MRI short axis cine views we assessed RVEF and
LVEF by conventional manual tracing of endocardial bor-
ders in systole and diastole in 133 subjects (normal sub-
jects = 28 and patients with dilated cardiomyopathy
(DCM = 105) in a 1,5 T MR-system. MAPSE and TAPSE
were measured on a 4-chamber MR-images. NTproBNP
levels were quantified using a Roche Diagnostics Kit.
Results
All parameters showed significant differences between
DCMP and normal subjects. LVEDD (64 ± 0.8 vs. 52 ± 0.9
mm), RVEDD (49 ± 0.8 vs. 44 ± 0.8%), LVEF (37 ± 1.3 vs.
67 ± 1%), RVEF (37 ± 1.9 vs. 53 ± 1.5%) as well as MAPSE
(9.3 ± 1 vs. 13.5 ± 0.6 mm) and TAPSE (18 ± 1 vs. 22.1 ±
1 mm) were significantly reduced in DCM (p < 0,001 for
all). NTproBNP was significantly increased in all patients
with DCM (2706 ± 564 ng/l, normal value < 450 ng/l).
MAPSE and TAPSE correlated well with LVEF and RVEF
respectively (r = 0.64 resp. 0.52 p < 0.001). NTproBNP
inversely correlated well with LVEF (r = -0.763 p < 0,001)
RVEF (r = -0.47 p < 0.0001), as well as MAPSE (r = -0.52 p
< 0.0001) and weakly albeit significantly with TAPSE (r =
-0.29 p = 0.0043). Furthermore the measurement of
MAPSE and TAPSE was less time consuming than conven-
tional three-dimensional quantitative assessment of LVEF
and RVEF (approximately 30 sec vs. 3–4 min) and inde-
pendent of myocardial to blood contrast.
Conclusion
MAPSE and TAPSE can be easily assessed on MR-images
and are valid parameters for the accurate and fast estima-
tion of LVEF and RVEF. MAPSE and TAPSE correlated well
to NTproBNP, however the prognostic value of MAPSE/
TAPSE in heart failure merits further investigation in
future longitudinal studies.
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